Can Low Iron Be a Sign of Cancer? What You Need to Know

Iron deficiency anemia is one of the more reliable early warning signs of several cancers, particularly those in the gastrointestinal tract. A large population-based study found that people with iron deficiency anemia had roughly double the overall cancer risk compared to the general population.¹ That does not mean low iron usually means cancer, and in fact the majority of iron-deficient people have a benign explanation. But the connection is strong enough that medical guidelines now call for cancer screening in specific groups when iron deficiency anemia shows up without an obvious cause.

How Cancer Causes Iron Deficiency

There are two distinct ways a tumor can drain your iron. The first is straightforward: bleeding. Cancers in the colon, stomach, and other parts of the digestive tract often cause slow, chronic blood loss that you may not notice. Each red blood cell that leaves carries iron with it, and over weeks or months, the body’s stores run dry. This is called absolute iron deficiency because the iron is physically gone from the body.²

The second pathway is sneakier. Tumors trigger inflammation, and the body’s inflammatory response ramps up production of a hormone called hepcidin. Hepcidin’s job is to block iron from entering the bloodstream: it shuts down absorption from food in the gut and locks iron inside storage cells so it cannot be recycled. The iron is still technically in your body, but your bone marrow can’t access it to make red blood cells. This is called functional iron deficiency, and it can show up even when standard iron stores look adequate on a basic blood test.³ In many cancer patients, both pathways operate at the same time, which is part of why the anemia can become severe.

Which Cancers Are Most Strongly Linked

Colorectal cancer sits at the top of the list. Iron deficiency anemia is considered the most common symptom of colorectal cancer that shows up outside the gut itself.² Right-sided colon tumors are especially prone to causing anemia because blood from these lesions mixes with stool over a longer transit and is less likely to be noticed by the patient. A person might feel tired, look pale, and have no digestive complaints at all, yet have a tumor bleeding slowly for months.

Stomach and esophageal cancers follow a similar logic. Tumors in the upper digestive tract bleed and also impair nutrient absorption. Research from Germany has documented the association between iron deficiency anemia and subsequent diagnosis of both stomach and colorectal cancers.⁴

Gynecological cancers, especially uterine and endometrial cancer, can present as iron deficiency through abnormal bleeding. In a study of women with postmenopausal bleeding, endometrial cancer accounted for a portion of cases with severe anemia.⁵ This is an important consideration because postmenopausal bleeding combined with anemia is a red flag that most gynecologists take seriously.

Blood cancers work through a different mechanism entirely. In multiple myeloma, for example, almost all patients develop significant anemia. The cancer cells flood the bone marrow with inflammatory signals that jack up hepcidin, locking iron away from the very cells trying to make red blood cells.⁶ Other blood cancers such as leukemia and lymphoma can crowd out normal blood-producing cells in the marrow, leading to anemia through a combination of displacement and inflammation.

Less intuitively, cancers of the kidney, bladder, and liver have also been linked to iron deficiency anemia. A study tracking over 4,300 patients with iron deficiency anemia found elevated cancer rates in these organs as well, with kidney cancer showing the strongest individual association at about five times the expected rate.⁷ Kidney and bladder tumors can bleed into the urine, and liver disease disrupts iron metabolism directly, so these connections have plausible mechanisms even though they are less commonly discussed than the colorectal link.

Putting the Risk in Perspective

The numbers sound alarming out of context, so it helps to see them clearly. In the large Taiwanese population study mentioned above, people with iron deficiency anemia had a standardized incidence ratio (a measure comparing observed cancer cases to expected ones) of about 2.15, meaning roughly double the cancer rate of the general population. That held for both men and women and across age groups.¹

But “double the risk” doesn’t mean half of all iron-deficient people get cancer. In a separate study of over 4,300 patients with iron deficiency anemia, about 3% were diagnosed with cancer within a year.⁷ That means 97% were not. The elevated risk is real and clinically important, especially for guiding who needs further testing, but it is nowhere near a guarantee. Iron deficiency is extremely common worldwide, and the vast majority of cases stem from diet, menstruation, or non-cancerous conditions.

Who Gets Investigated and How

Medical guidelines draw a clear line based on age and sex. For men of any age and for postmenopausal women, new iron deficiency anemia without an obvious benign explanation is treated as a strong indication for scoping both the upper and lower digestive tract, a procedure called bidirectional endoscopy.⁸ The logic is simple: in these groups, menstrual blood loss is not an explanation, so the iron has to be going somewhere, and a GI cancer is high enough on the list to justify looking.

For premenopausal women, the picture is murkier. Heavy periods are extremely common and explain most cases. Guidelines are more conditional, recommending endoscopy mainly when there are additional red flags such as GI symptoms, a family history of colorectal cancer, or failure to improve with iron supplements. That said, a study of patients under 45 with iron deficiency anemia found that nearly 29% had significant findings on upper endoscopy, and about 8% had lower GI lesions on colonoscopy. Interestingly, patients without any GI symptoms were actually more likely to have clinically significant findings than those with symptoms.⁹ That finding challenges the common assumption that if you feel fine in your stomach and gut, there’s nothing to find.

When both an upper and lower scope are done together rather than just one, the diagnostic yield jumps dramatically. One study found the cause of iron deficiency anemia in about 90% of patients who had both procedures, compared to only about 11% when just one was performed.¹⁰ The upper and lower GI tracts can harbor completely different problems, and doing only a colonoscopy misses treatable conditions in the stomach or small bowel.

Can a Stool Test Replace a Colonoscopy?

You might wonder whether a simple stool test, which detects tiny amounts of blood in the feces, could serve as a screen before committing to endoscopy. The fecal immunochemical test (FIT) is already widely used for colorectal cancer screening in the general population, and researchers have studied whether it can help triage iron-deficient patients. A systematic review found that FIT is highly sensitive for colorectal cancer in iron-deficient patients, but not sensitive enough to be used as a rule-out. In other words, a positive FIT result is a strong signal, but a negative result does not mean you’re in the clear.¹¹

This matters practically because colonoscopy availability is a real bottleneck in many health systems. One study examined whether combining FIT results with iron deficiency status could better identify who truly needed a colonoscopy. Among asymptomatic men with both a positive FIT and iron deficiency anemia, roughly 29% had advanced colorectal neoplasia, compared to about 1.5% of those with neither condition.¹² That kind of stratification helps doctors prioritize the most urgent cases. But for men and postmenopausal women with established iron deficiency anemia, endoscopy remains the accepted standard even when FIT comes back negative.¹¹

The Many Non-Cancer Causes of Low Iron

Before anyone spirals, it’s worth remembering that iron deficiency is among the most common nutritional deficiencies in the world, and cancer is a relatively uncommon cause. The list of benign explanations is long:

Menstruation: Heavy periods are the single most common reason premenopausal women become iron deficient. It’s so common that fatigue and weakness from chronic blood loss often get normalized as “just how things are.”
Diet: Vegetarian and vegan diets, or diets simply low in red meat and fortified foods, can lead to inadequate iron intake over time.
Celiac disease: Damage to the small intestine lining impairs iron absorption. Guidelines recommend taking small bowel biopsies to rule out celiac disease when investigating iron deficiency anemia.¹³
H. pylori infection: This common stomach bacterium can cause iron deficiency even without producing ulcers or obvious symptoms. Eradicating the infection has been shown to resolve previously treatment-resistant iron deficiency anemia, providing strong evidence for a direct cause-and-effect relationship.¹⁴
Chronic kidney disease: The kidneys produce a hormone that stimulates red blood cell production, and kidney impairment disrupts this process alongside iron metabolism.
Pregnancy and breastfeeding: The body’s iron demands rise sharply during pregnancy, and many women enter pregnancy already borderline deficient.
Blood donation: Regular donors frequently deplete their iron stores, sometimes without realizing it.

Iron deficiency can also result from inflammatory conditions like rheumatoid arthritis, inflammatory bowel disease, and heart failure, where the hepcidin-mediated mechanism locks iron away from circulation in a pattern that mimics what cancer does.¹⁵ A doctor’s job is to figure out which mechanism is at play, which is why a single ferritin level rarely tells the whole story.

Why Iron Deficiency Often Gets Missed or Dismissed

One frustrating pattern in clinical practice is how long iron deficiency can linger before anyone takes it seriously. The most common symptoms are fatigue and weakness, and a retrospective study found these were the leading complaints across both sexes. The problem is that these symptoms are vague enough to be attributed to stress, poor sleep, or aging.¹⁶ Women of reproductive age are especially likely to have their symptoms normalized, both by themselves and by their doctors, because menstruation provides a ready-made explanation that doesn’t require further investigation.

The diagnostic threshold for iron deficiency itself is also debated, which adds to the confusion. Traditional cutoffs for “low” ferritin have been as low as 15 ng/mL in some guidelines, but research increasingly suggests this misses a lot of genuinely iron-deficient people. A multicountry study found that using physiologically based thresholds of around 25 μg/L for women nearly doubled the estimated prevalence of iron deficiency compared to older guidance.¹⁷ An analysis of primary care data similarly showed that raising the ferritin cutoff from 15 to 45 ng/mL substantially changed how many patients were flagged as iron deficient.¹⁸ If the threshold is set too low, a patient with early iron depletion may be told their labs are “normal” and sent home without any workup.

The practical consequence is that iron deficiency can be present, even functionally significant, long before someone meets the criteria for anemia. A study of patients with chronic conditions found that iron deficiency was clinically relevant in the majority of cases regardless of whether anemia had developed.¹⁹ Waiting for hemoglobin to drop before investigating means missing a window where the underlying cause, whether cancerous or not, could have been caught earlier.

How Tumors Hijack Iron for Their Own Growth

There’s a less commonly discussed angle to the iron-and-cancer story that goes beyond cancer merely causing iron deficiency. Tumor cells are metabolically hyperactive, and they need iron to sustain their rapid division. Many cancers upregulate a protein on their surface called the transferrin receptor, which acts as a gatekeeper for pulling iron out of the bloodstream and into cells. Overexpression of this receptor is common in solid tumors and has been linked to worse outcomes.²⁰ Researchers have identified this receptor as a potential tumor marker in esophageal squamous cell cancer as well.²¹

This creates something of a biological tug-of-war. The tumor upregulates its own iron import machinery to feed its growth, while simultaneously triggering systemic inflammation that restricts iron availability throughout the rest of the body. The net effect is that the patient becomes iron deficient while the tumor cells remain relatively iron-replete. Hepcidin sits at the center of this system: produced by the liver in response to inflammation, it blocks iron from entering circulation. Cancer researchers are now exploring whether manipulating hepcidin expression could starve tumors of the iron they need.²² The transferrin receptor itself is also being investigated as a delivery vehicle for cytotoxic drugs, essentially using the tumor’s iron hunger against it.²⁰

When to Push for a Workup

If your blood work shows low iron or iron deficiency anemia, the urgency of further testing depends on your profile. Men and postmenopausal women should have an explanation identified, and if one is not obvious, endoscopy is warranted. Simply treating the anemia with iron supplements without investigating the cause is a well-documented pitfall: it can temporarily improve the numbers while an underlying cancer continues to grow undetected.

Premenopausal women face a judgment call. If heavy menstruation fully accounts for the iron loss and the anemia resolves with treatment, many clinicians will monitor rather than scope. But if anemia persists despite adequate iron replacement, if there’s a family history of GI cancer, or if there are any new bowel symptoms, pushing for further investigation is reasonable. The study showing that asymptomatic young patients frequently had significant findings on endoscopy is a useful data point to raise with a reluctant provider.⁹

Beyond the GI tract, your doctor should also consider testing for celiac disease, H. pylori, and kidney function as part of any iron deficiency workup. These conditions are treatable, and catching them often resolves the anemia completely without any need for endoscopy. The diagnostic process is not just about ruling out cancer; it’s about finding whatever is causing your body to lose or lock away iron, and fixing it.

1
PubMed Central. Risk of Cancer in Patients with Iron Deficiency Anemia: A Nationwide Population-Based Study
2
PubMed Central. Iron Deficiency Anemia in Colorectal Cancer Patients: Is Preoperative Intravenous Iron Infusion Indicated? A Narrative Review of the Literature
3
PubMed Central. Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation
4
PubMed Central. Association between iron deficiency anemia and subsequent stomach and colorectal cancer diagnosis in Germany
5
PubMed Central. Assessment of paraclinical characteristics in peri- and postmenopausal bleeding women: is there a correlation between hemoglobin levels and ultrasonic indices?
6
PubMed Central. Iron in multiple myeloma
7
Blood. Chronic Iron Deficiency Anemia and Cancer Risk
8
Cancer Research. Abstract 3596: Risk of gastrointestinal cancer by sex and age in U.S. veterans with new-onset iron deficiency anemia
9
PubMed Central. Diagnostic yield of bidirectional endoscopy for iron deficiency anemia in young patients
10
PubMed. Diagnostic yield of bidirectional gastrointestinal system endoscopy for iron deficiency anemia
11
Critical Reviews in Oncology/Hematology. Faecal immunochemical tests can improve colonoscopy triage in patients with iron deficiency: A systematic review and meta-analysis
12
PubMed Central. A Combination of Fecal Immunochemical Test Results and Iron Deficiency Anemia for Detection of Advanced Colorectal Neoplasia in Asymptomatic Men
13
PubMed Central. H.pylori associated with iron deficiency anemia even in celiac disease patients; strongly evidence based but weakly reflected in practice
14
PubMed. Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis
15
PubMed Central. Iron Deficiency and Iron Deficiency Anemia in Chronic Disease-Common, Important, and Treatable
16
PubMed Central. Factors Associated with Delayed Diagnosis of Iron Deficiency Anemia in Egyptian Patients: A Retrospective Cohort Study
17
The Lancet Global Health. Physiologically based serum ferritin thresholds for iron deficiency in non-pregnant women and young children: a multicountry cross-sectional study
18
JAMA Network Open. Ferritin Cutoffs and Diagnosis of Iron Deficiency in Primary Care
19
PubMed Central. Threshold Ferritin Concentrations Reflecting Early Iron Deficiency Based on Hepcidin and Soluble Transferrin Receptor Serum Levels in Patients with Absolute Iron Deficiency
20
PubMed Central. Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity
21
PubMed Central. Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy
22
PubMed Central. Distinctive modulation of hepcidin in cancer and its therapeutic relevance